Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ruiwan Chen"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundMetabolic reprogramming is a well-known hallmark of cancer. Systematical identification of clinically relevant metabolic subtypes of Hepatocellular carcinoma (HCC) is critical to understand tumor heterogeneity and develop efficient treatmen
Externí odkaz:
https://doaj.org/article/ad3dbbe627394af7845b3e3f14be2a0f
Autor:
Yuanjian Fan, Ruiwan Chen, Ying Lu, Ying Lin, Yunjian Zhang, Nan Shao, Shenming Wang, Dahong Nie, Zhen Shan
Publikováno v:
The Breast Journal, Vol 2023 (2023)
Background. Intraoperative radiotherapy (IORT) is a novel promising technology that may replace external beam radiation therapy (EBRT) as boost for patients receiving breast-conserving surgery. To better evaluate the efficacy of IORT using low-kilovo
Externí odkaz:
https://doaj.org/article/667dcf12a9654a438827308ae62446b8
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Baseline C-reactive protein (CRP) has been determined as a prognostic factor in nasopharyngeal carcinoma (NPC). This study was designed to further evaluate the impact of CRP kinetics on NPC patients. Thousand three hundred and seventy eight NPC patie
Externí odkaz:
https://doaj.org/article/b55f9c1111124b49a34d46527d40c956
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1442
Volume 15
Issue 5
Pages: 1442
The hallmark of pancreatic ductal adenocarcinoma (PDAC) is an exuberant tumor microenvironment (TME) comprised of diverse cell types that play key roles in carcinogenesis, chemo-resistance, and immune evasion. Here, we propose a gene signature score
Publikováno v:
Cancer Management and Research
Yu Zhou,1 Zi Yin,1 Baohua Hou,1 Min Yu,1 Ruiwan Chen,2 Haosheng Jin,1 Zhixiang Jian11Department of General Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, People’s Republic of China; 2Department of
Publikováno v:
SSRN Electronic Journal.
Background: Metabolic reprogramming is a well-known hallmark of cancer. Systematical identification of clinically relevant metabolic subtypes of Hepatocellular carcinoma (HCC) is critical to understand tumor heterogeneity and develop efficient treatm
Publikováno v:
OncoTargets and therapy
Gang Guo,1,* Moushun Fu,2,* Shuxiang Wei,3 Ruiwan Chen4 1Department of Ophthalmology, Tongjiang Hospital of Guangdong, Foshan, 2Department of Otorhinolaryngology, Tongjiang Hospital of Guangdong, Foshan, 3Department of Endocrinology, Tongjiang Hospit
Autor:
Zhenwei Peng, Yong Chen, Li-Xia Lu, Cheng-Tao Wang, Sha-Sha He, Yufeng Ren, Ruiwan Chen, Yan Wang, Shao-Bo Liang
Publikováno v:
Cancer Management and Research
Sha-Sha He,1,* Cheng-Tao Wang,1,* Zhen-Wei Peng,1,* Yu-Feng Ren,1 Li-Xia Lu,2 Rui-Wan Chen,1 Shao-Bo Liang,2,3 Yan Wang,1 Yong Chen11Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 51008
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
Baseline C-reactive protein (CRP) has been determined as a prognostic factor in nasopharyngeal carcinoma (NPC). This study was designed to further evaluate the impact of CRP kinetics on NPC patients. Thousand three hundred and seventy eight NPC patie
Publikováno v:
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. :138-149
Purpose: The aim of the study was to evaluate the association between clinicopathological and prognostic significance and circulating tumor cells (CTCs) in patients with head and neck cancer. Methods: We searched PubMed, MEDLINE, BioMed, and EMbase d